Clovis Oncology Denmark ApS Financials, key figures and credit report
Gross profit -1 276.5 kDKK FY 2023 -200.7% vs 2022
EBIT -1 285.5 kDKK FY 2023 -94.7% vs 2022
Net debt - 731.3 kDKK FY 2023 -281.7% vs 2022
Quick ratio 0.9 FY 2023 +0.1 vs 2022
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 924.97 | 1 657.62 | 1 539.04 | 1 268.08 | -1 276.50 |
| Employee benefit expenses | -1 816.10 | -1 562.92 | -1 450.89 | -1 928.25 | |
| Other operating expenses | -8.99 | ||||
| EBIT | 108.87 | 94.70 | 88.15 | - 660.17 | -1 285.49 |
| Other financial income | 121.44 | 41.35 | 0.02 | ||
| Other financial expenses | - 145.03 | -78.39 | -32.12 | -21.67 | -4.76 |
| Pre-tax profit | 85.29 | 57.67 | 56.05 | - 681.84 | -1 290.25 |
| Income taxes | -20.10 | -13.77 | -9.71 | -1.55 | |
| Net earnings | 65.19 | 43.90 | 46.34 | - 683.39 | -1 290.25 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current other receivables | 5.48 | 42.85 | 134.54 | 124.11 | |
| Current deferred tax assets | 6.00 | 12.00 | |||
| Short term receivables total | 5.48 | 42.85 | 134.54 | 130.11 | 12.00 |
| Cash and bank deposits | 821.38 | 1 347.57 | 990.63 | 1 509.94 | 890.28 |
| Cash and cash equivalents | 821.38 | 1 347.57 | 990.63 | 1 509.94 | 890.28 |
| Balance sheet total (assets) | 826.86 | 1 390.43 | 1 125.17 | 1 640.05 | 902.28 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | 93.64 | 158.83 | 202.73 | 249.06 | 884.04 |
| Profit of the financial year | 65.19 | 43.90 | 46.34 | - 683.39 | -1 290.25 |
| Shareholders equity total | 208.83 | 252.73 | 299.06 | - 384.33 | - 356.20 |
| Provisions | 250.00 | ||||
| Non-current other liabilities | 40.73 | 156.24 | |||
| Non-current liabilities total | 40.73 | 156.24 | |||
| Current trade creditors | 143.04 | 73.52 | 80.45 | 80.20 | 796.25 |
| Current owed to group member | 113.76 | 412.73 | 431.34 | 1 318.37 | 158.99 |
| Short-term deferred tax liabilities | 12.87 | 7.75 | |||
| Other non-interest bearing current liabilities | 307.63 | 487.46 | 314.31 | 625.80 | 53.24 |
| Current liabilities total | 577.30 | 981.46 | 826.11 | 2 024.38 | 1 008.49 |
| Balance sheet total (liabilities) | 826.86 | 1 390.43 | 1 125.17 | 1 640.05 | 902.28 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated